CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 8,168 enrolled
Drug / intervention
Observational (registry)combination
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04334291
NCT04334291N/ACompleted

International COVID19 Clinical Evaluation Registry: HOPECOVID19. (Health Outcome Predictive Evaluation for COVID19)

IVAN J NUÑEZ GIL·observational·Posted Apr 6, 2020·Updated Jan 25, 2022

In Brief

An observational study evaluating Observational (registry) for COVID 19. Completed, enrolled 8,168 participants across 1 site.

Detailed Summary

The investigators propose to select all COVID 19 patients attended in any health center (with in hospital beds), who have been discharged or have died at the time of the evaluation. The main objective of the present study is to carefully characterize the clinical profile of patients infected with COVID-19 in order to develop a simple prognostic clinical score allowing, in selected cases, rapid logistic decision making (discharge with follow-up, referral to provisional/field hospitals or admission to more complex hospital centers). As secondary objectives, the analysis of the risk-adjusted influence of treatments and previous comorbidities of patients infected with the disease will be performed.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsCOVID 19
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 6, 2020
Enrollment StartMar 23, 2020
Primary CompletionMay 1, 2020
Study CompletionMay 31, 2020
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 6.2 years ago

Interventions

Observational (registry)combination

Observational study.